Results 121 to 130 of about 3,156 (181)

Correction to: Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa. [PDF]

open access: yesAm J Clin Dermatol
Marinkovich MP   +11 more
europepmc   +1 more source

Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase-9 expression. [PDF]

open access: yesJ Dermatol
Dorfer S   +14 more
europepmc   +1 more source

Enhanced HDR-mediated correction of heterozygous COL7A1 mutations for recessive dystrophic epidermolysis bullosa. [PDF]

open access: yesMol Ther Nucleic Acids
Hunt JMT   +13 more
europepmc   +1 more source

Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa. [PDF]

open access: yesAm J Clin Dermatol
Marinkovich MP   +11 more
europepmc   +1 more source

A case of recessive dystrophic epidermolysis bullosa.

open access: yesThe Turkish journal of pediatrics, 1988
K Kocabay   +3 more
openaire   +2 more sources

A homozygous nonsense mutation identified in <i>COL7A1</i> in a family with autosomal recessive dystrophic epidermolysis bullosa. [PDF]

open access: yesJ Med Life
Ayub M   +13 more
europepmc   +1 more source

A case of dystrophic epidermolysis bullosa with a rare COL7A1 variant. [PDF]

open access: yesAn Bras Dermatol
Amoedo P, Grangeia A, Peralta L, Mota A.
europepmc   +1 more source

Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa: A Randomized Crossover Trial.

open access: yesJAMA Dermatol
Calvo M   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy